欢迎来到天天文库
浏览记录
ID:33183377
大小:5.69 MB
页数:69页
时间:2019-02-21
《化痰逐瘀法治疗慢性痛风的临床研究》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、中国中医科学院硕士学位论文化痰逐瘀法治疗慢性通风的临床研究姓名:樊蕾申请学位级别:硕士专业:中医内科学指导教师:殷海波;姜泉20120528化痰逐瘀法治疗陵性痛风的·临床研究摘要慢性痛风主要表现为发作频繁、间歇期不明显、多关节受累、关节炎持续、骨质侵蚀及关节功能丧失,给家庭和社会造成了沉重的负担。本病常与代谢综合征、高脂血症、糖尿病、高血压病以及心脑血管病伴发,近年来,痛风的患病率逐渐增高,并出现有年轻化趋势。慢性痛风治疗目标是坚持降尿酸治疗以便减少发作次数和减缓过多的尿酸在关节及组织中的沉积。降尿酸药物分为两类,一类是促尿酸排泄药,另一类是抑制尿酸生成药,但这些药物均
2、存在不同程度的毒副作用,长期应用多种药物的治疗方案导致的毒副作用叠加,安全性下降,成为其临床应用的瓶颁。因此,在我院JxL湿病科积累的多年临床经验基础上,结合目前痛风发病规律,针对慢性痛风以痰瘀互阻多见的特点,拟定以“化痰逐瘀’’为主要治则的中药复方,在前期临床观察中取得了较好的疗效。目前临床研究观察期多较短,尚缺乏中长期疗效观察,为进一步评价化痰逐瘀法治疗慢性痛风的临床疗效、安全性,拟丌展本l临床研究。.,,本研究为开放性研究,病例来源于广安门医院风湿科门诊,将30例慢性痛风患者予中药痰瘀方治疗,经过3个月的观察,评价患者疾病疗效、实验室指标改善情况及安全性,并与同期
3、研究别嘌呤醇组进行比较,研究结果如下:血尿酸改善方面,中药组在治疗1个月后未显示出统计学差异,治疗2、3个月时均显示出统计学差异(P4、第1个月即显示出统计学差异(P5、chronicgoutalefrequentseizures,multiplejointinvolvement,continuingarthritis,boneerosionandlossofjointfunctions.Itoftenassociatedwithmetabolicsymdrome,hyperlipidemia,diabetes,hypertensionandcardiovasculardisease.Itleadstoheavyburdenstofamiliesandsociety.Inrecentyears,theprevalenceofgoutwa6、sgraduallyincreased.Ithappensmoreandmoreamongyoungadults.Uricacidloweringdrugsfallintotwocategories,onecategoryistopromoteuricacidexcretion,theotheristosuppresstheproductionofuricaciddrug,butthesedrugshavetoxicsideeffectsinlong-termapplication.Basedontheclinicalexperiencesofourdepartment7、,accordingtothelawofthedisease,aimingatthefeaturesofchronicgoutbyobstructionofphlegmandbloodstasis,weprescribedacompoundrecipewiththetherapeuticprincipleofresolvingphlegmandremovingbloodstasis.Intheearlyclinicalobservation,theprescriptionhadgotanobvioustherapeuticeffect.A
4、第1个月即显示出统计学差异(P5、chronicgoutalefrequentseizures,multiplejointinvolvement,continuingarthritis,boneerosionandlossofjointfunctions.Itoftenassociatedwithmetabolicsymdrome,hyperlipidemia,diabetes,hypertensionandcardiovasculardisease.Itleadstoheavyburdenstofamiliesandsociety.Inrecentyears,theprevalenceofgoutwa6、sgraduallyincreased.Ithappensmoreandmoreamongyoungadults.Uricacidloweringdrugsfallintotwocategories,onecategoryistopromoteuricacidexcretion,theotheristosuppresstheproductionofuricaciddrug,butthesedrugshavetoxicsideeffectsinlong-termapplication.Basedontheclinicalexperiencesofourdepartment7、,accordingtothelawofthedisease,aimingatthefeaturesofchronicgoutbyobstructionofphlegmandbloodstasis,weprescribedacompoundrecipewiththetherapeuticprincipleofresolvingphlegmandremovingbloodstasis.Intheearlyclinicalobservation,theprescriptionhadgotanobvioustherapeuticeffect.A
5、chronicgoutalefrequentseizures,multiplejointinvolvement,continuingarthritis,boneerosionandlossofjointfunctions.Itoftenassociatedwithmetabolicsymdrome,hyperlipidemia,diabetes,hypertensionandcardiovasculardisease.Itleadstoheavyburdenstofamiliesandsociety.Inrecentyears,theprevalenceofgoutwa
6、sgraduallyincreased.Ithappensmoreandmoreamongyoungadults.Uricacidloweringdrugsfallintotwocategories,onecategoryistopromoteuricacidexcretion,theotheristosuppresstheproductionofuricaciddrug,butthesedrugshavetoxicsideeffectsinlong-termapplication.Basedontheclinicalexperiencesofourdepartment
7、,accordingtothelawofthedisease,aimingatthefeaturesofchronicgoutbyobstructionofphlegmandbloodstasis,weprescribedacompoundrecipewiththetherapeuticprincipleofresolvingphlegmandremovingbloodstasis.Intheearlyclinicalobservation,theprescriptionhadgotanobvioustherapeuticeffect.A
此文档下载收益归作者所有